Erdafitinib
Especificaciones
1346242-81-6Número CAS
807-395-6Número CE
N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamineNombre IUPAC
C25H30N6O2Fórmula química
446.5 g/molPeso molecular
Erdafitinib; 1346242-81-6; Balversa; 890E37NHMV; DTXSID001027936; 1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-; N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine; N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine; erdafitinibum; N'-(3,5-dimethoxyphenyl)-N'-(3-(1-methylpyrazol-4-yl)quinoxalin-6-yl)-N-propan-2-ylethane-1,2-diamine; N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-1,2-ethanediamine; RefChem:57639; DTXCID201513503; JNJ-42756493; N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine; MFCD28502040; JNJ 42756493; N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-N-{2-[(propan-2-yl)amino]ethyl}quinoxalin-6-amine; Erdafitinib [INN]; Erdafitinib [USAN:INN]; UNII-890E37NHMV; Erdafitinib?; Balversa (TN); N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine; JNJ 42756493;; JNJ42756493; Erdafitinib (Standard); ERDAFITINIB [MI]; ERDAFITINIB [JAN]; ERDAFITINIB [USAN]; ERDAFITINIB [WHO-DD]; Erdafitinib (JAN/USAN/INN); GTPL9039; orb1303841; SCHEMBL2583760; CHEMBL3545376; SCHEMBL29359988; ERDAFITINIB [ORANGE BOOK]; Erdafitinib; JNJ-42756493; CHEBI:232556; GLXC-10828; HMS5086O09; Erdafitinib (JNJ-42756493); JNJ-42756493 (Erdafitinib); EX-A2564; BDBM50525939; EBC-17115; HY-18708R; NSC781556; s8401; AKOS030526429; compound 4 [WO2011135376]; CCG-269200; CS-4988; DB12147; FE76167; NSC-781556; SB16854; NCGC00475735-01; AC-30222; AS-35040; HY-18708; N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine; SY224702; NS00073477; D10927; BRD-K84868168-001-01-0; Q27077213; PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493; 1-((3,5-Dimethoxyphenyl)(3-(1-methyl-4-pyrazolyl)-6-quinoxalinyl)amino)-2-(isopropylamino)ethane; 5SF; N'-(3,5-dimethoxyphenyl)-N-isopropyl-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine; N1-(3,5-Dimethoxyphenyl)-N2-isopropyl-N1-[3-(1-methyl-4-pyrazolyl)-6-quinoxalinyl]-1,2-ethanediamineSinónimos
Productos que contienen Erdafitinib
발베사정5밀리그램(얼다피티닙)발베사정4밀리그램(얼다피티닙)발베사정3밀리그램(얼다피티닙)バルバーサ錠3mg／バルバーサ錠4mg／バルバーサ錠5mgBALVERSA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULABALVERSA 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULABALVERSA 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULABALVERSA 5 mg, comprimé pelliculéBALVERSA 4 mg, comprimés pelliculésBALVERSA 3 mg, comprimés pelliculésErdafitinibERDAFITINIB
Página 1 de 2
Empresas que venden Erdafitinib
JM
Jiangsu Magic Biotechnology Co., LtdChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChina
JI
Janssen-Cilag International N.VSpainJC
JANSSEN CILAG INTERNATIONAL NVFrance(주
(주)한국얀센Republic of Koreaヤン
ヤンセンファーマ株式会社Japan
NP
NANJING POPE BIO-TECH R&D Co., Ltd.China